Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

Multiple primary lung cancer (MPLC) remains a tough challenge to diagnose and treat. Although neoadjuvant immunotherapy has shown promising results in early stage non-small cell lung cancer, whether such modality can benefit all primary lesions remains unclear. Herein, we performed integrated multio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Yin, Kai, Liu, Si-Yang, Yan, Li-Xu, Su, Jian, Wu, Yi-Long, Zhang, Xu-Chao, Zhong, Wen-Zhao, Yang, Xue-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025811/
https://www.ncbi.nlm.nih.gov/pubmed/33820821
http://dx.doi.org/10.1136/jitc-2020-002312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025811/
https://www.ncbi.nlm.nih.gov/pubmed/33820821
http://dx.doi.org/10.1136/jitc-2020-002312

Ejemplares similares